XT
COYA icon

XTX Topco’s Coya Therapeutics COYA Stock Holding History

XTX Topco’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
41,401
-5,937
-13% -$27.5K ﹤0.01% 3095
2026
Q1 		$187K Buy
47,338
+14,268
+43% +$66.7K ﹤0.01% 2868
2025
Q4 		$192K Buy
+33,070
New +$201K 0.01% 2420
2025
Q1 		– Sell
-10,299
Closed -$59K – 2511
2024
Q4 		$59K Buy
+10,299
New +$70.2K ﹤0.01% 1870

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

XTX Topco's COYA Position: Q2 2026 in Review

XTX Topco reduced its Coya Therapeutics (COYA) stake by 13% in Q2 2026, selling an estimated $27.5K and leaving 41,401 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

XTX Topco first reported a position in COYA in Q4 2024 and has held it in 4 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • XTX Topco held 41,401 shares of Coya Therapeutics worth $242K as of Q2 2026.
  • XTX Topco sold 5,937 Coya Therapeutics shares in Q2 2026, an estimated $27.5K.
  • Coya Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3095 holding.
  • XTX Topco first reported a position in Coya Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.